The Allstate Corporation ALL
262.27 USD -1.72 (-0.65%)
Nov 3, 2026, 3:16 PM EST
260.01 Day range 263.00
191.25 52-week range 275.11
- YTD
- +26.00%
- 1 year
- +37.13%
Analyst view
Consensus: buy
Buy
Price target (mean) 269.27 +2.7% upside
Now 262.27
- Target (low)
- 191.00
- Target (mean)
- 269.27
- Target (high)
- 340.00
Ratings (0m) 25 11 buy · 10 hold · 4 sell
- Strong buy2
- Buy9
- Hold10
- Sell2
- Strong sell2
Recommendation trend
- This month 25
- 1 month ago 25
- 2 months ago 25
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 6.96 | 5.35 – 8.67 | 11.17 | -37.7% | 17.46B | +1.2% | 21 |
| Next quarter | 9.40 | 7.05 – 11.47 | 14.31 | -34.3% | 17.62B | +1.6% | 19 |
| Current year | 35.96 | 32.45 – 39.19 | 34.83 | +3.3% | 70.19B | +3.7% | 23 |
| Next year | 28.11 | 23.55 – 34.39 | 35.96 | -21.8% | 72.68B | +3.5% | 22 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Wells Fargo | Upgrade | Underweight | Equal-Weight |
| Oct 12, 2026 | Keefe, Bruyette & Woods | Maintained | Underperform | Underperform |
| Oct 7, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Oct 7, 2026 | Barclays | Maintained | Underweight | Underweight |
| Oct 6, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 2, 2026 | Citigroup | Maintained | Sell | Sell |
| Oct 1, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Sep 18, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Sep 16, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 28, 2026 | Argus Research | Downgrade | Buy | Hold |
| Aug 20, 2026 | Keefe, Bruyette & Woods | Downgrade | Market Perform | Underperform |
| Aug 13, 2026 | BMO Capital | Maintained | Buy | Buy |
| Aug 11, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 11, 2026 | Citigroup | Downgrade | Neutral | Sell |
| Aug 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 10, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Aug 10, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 10, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Freedom Broker | Upgrade | Hold | Buy |
| Aug 7, 2026 | Wells Fargo | Downgrade | Equal-Weight | Underweight |
| Aug 6, 2026 | Roth MKM | Maintained | Buy | Buy |
| Aug 6, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Aug 6, 2026 | Barclays | Maintained | Underweight | Underweight |
| Jul 15, 2026 | UBS | Downgrade | Buy | Neutral |
| Jul 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 10, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 9, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Jul 9, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 8, 2026 | Keefe, Bruyette & Woods | Maintained | Market Perform | Market Perform |
| Jul 7, 2026 | Barclays | Maintained | Underweight | Underweight |
